Lymphocyte Depleted Hodgkin Lymphoma, Lymph Nodes of Inguinal Region and Lower Limb (C81.35)

Name of the Condition

• Common Name: Lymphocyte Depleted Hodgkin Lymphoma, Lymph Nodes of Inguinal Region and Lower Limb
• Medical Terms: LD Hodgkin Lymphoma, Lymphocyte-Depleted Hodgkin Disease (inguinal region and lower limb lymph nodes)

Summary

Lymphocyte depleted Hodgkin lymphoma (LD Hodgkin lymphoma) is a rare and aggressive subtype of Hodgkin lymphoma. It is characterized by a scarcity of lymphocytes and a predominance of Reed-Sternberg cells in affected lymph nodes or tissues. This subtype often presents at an advanced stage and may involve extranodal sites, such as the liver or bone marrow. LD Hodgkin lymphoma is associated with a poorer prognosis compared to other Hodgkin lymphoma subtypes, though treatment advances have improved outcomes.

Causes

The exact cause of lymphocyte depleted Hodgkin lymphoma is not fully understood. It is thought to result from a combination of genetic mutations and environmental factors. Unlike other Hodgkin lymphoma subtypes, Epstein-Barr virus (EBV) is frequently associated with LD Hodgkin lymphoma, suggesting a potential viral role in its development. Genetic abnormalities and immune system dysregulation may also contribute.

Risk Factors

• Age: Most commonly diagnosed in adults, particularly those over 50.
• Immune Status: Weakened immunity (e.g., from HIV/AIDS or immunosuppressive therapy) increases risk.
• Epstein-Barr Virus: Prior infection is strongly associated with this subtype.
• Geographic/Environmental Factors: Some studies suggest higher incidence in certain regions, though specific triggers remain unclear.

Symptoms

• Painless swelling of lymph nodes in the inguinal region or lower limb.
• Unexplained weight loss, fever, or night sweats (B symptoms).
• Fatigue or weakness.
• Pruritus (itching) or skin rashes.
• In advanced cases, symptoms related to organ involvement (e.g., abdominal pain if spleen or liver is affected).

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging, and laboratory tests. A biopsy of the affected lymph node is essential to confirm the presence of Reed-Sternberg cells and assess lymphocyte depletion. Imaging (e.g., CT, PET scans) helps stage the disease and identify extranodal involvement. Blood tests may reveal anemia, elevated ESR, or abnormal liver function. Bone marrow biopsy may be performed if systemic spread is suspected.

Treatment Options

Treatment typically involves chemotherapy, often with regimens like ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine) or more intensive protocols for advanced disease. Radiation therapy may be used for localized disease. Stem cell transplantation is considered for relapsed or refractory cases. Immunotherapy (e.g., checkpoint inhibitors) is emerging as a treatment option. Treatment plans are tailored to the patient’s stage, overall health, and response to initial therapy.

Prognosis and Follow-Up

Prognosis for lymphocyte depleted Hodgkin lymphoma is generally poorer than other subtypes, but outcomes have improved with modern therapies. Survival rates depend on stage at diagnosis, response to treatment, and patient age/health. Regular follow-up with imaging, blood tests, and clinical exams is critical to monitor for recurrence or late effects (e.g., secondary cancers, cardiovascular issues). Long-term surveillance may be recommended.

Complications

• Disease progression or relapse.
• Treatment-related toxicities (e.g., cardiotoxicity from chemotherapy, lung damage from radiation).
• Secondary malignancies (e.g., leukemia, non-Hodgkin lymphoma).
• Infections due to immunosuppression.
• Chronic fatigue or reduced quality of life.

Lifestyle & Prevention

• Maintain a balanced diet and regular exercise to support overall health during and after treatment.
• Avoid smoking and limit alcohol, as these may worsen treatment side effects.
• Practice good hygiene to reduce infection risk, especially if immunosuppressed.
• Stay up-to-date with vaccinations (e.g., flu, pneumonia) as recommended by your provider.
• Seek mental health support to address anxiety or depression related to diagnosis.

When to Seek Professional Help

• Persistent or worsening lymph node swelling in the inguinal region or lower limb.
• Unexplained weight loss, fever, or night sweats lasting more than two weeks.
• Severe fatigue or weakness that interferes with daily activities.
• Signs of infection (e.g., fever, chills, cough) during or after treatment.
• New or worsening symptoms (e.g., pain, shortness of breath) that may indicate disease progression.

Tips for Medical Coders

When coding for C81.35, ensure the documentation specifies lymphocyte depleted Hodgkin lymphoma with involvement of the inguinal region and lower limb lymph nodes. Verify that the diagnosis aligns with histopathological confirmation (e.g., biopsy showing Reed-Sternberg cells and lymphocyte depletion). Document the site clearly to distinguish from other lymph node regions (e.g., head/neck or unspecified sites). Review clinical notes for staging details, as this may impact coding accuracy and subsequent treatment planning.